| 000 -LEADER |
|---|
| fixed length control field |
05370cam a2200457 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
20825272 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
CITU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20230215170811.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m |o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr |n||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
190126s2020 nju ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2019003905 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781119558200 (Adobe PDF) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781119558224 (ePub) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781119940777 (pbk.) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng. |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM267 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QW 45 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.7/922 |
| Edition number |
23 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Bacterial resistance to antibiotics : |
| Remainder of title |
from molecules to man / |
| Statement of responsibility, etc |
edited by Boyan B. Bonev, Nicholas M. Brown. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Hoboken, NJ : |
| Name of publisher, distributor, etc |
Wiley/Blackwell, |
| Date of publication, distribution, etc |
2020. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 500 ## - GENERAL NOTE |
|---|
| General note |
ABOUT THE AUTHOR<br/>BOYAN B. BONEV is Associate Professor in Biophysics and Structural Biology, Faculty of Medicine & Health Sciences, University of Nottingham, UK. Dr. Bonev heads the Biomembrane NMR labs and is co-Director of the Dynamic Nuclear Magnetization Facility.<br/><br/>NICHOLAS M. BROWN is clinical lead for medical microbiology at Addenbrooke's Hospital, Cambridge. He is previous President and current Director of Public and Professional Engagement, British Society for Antimicrobial Chemotherapy (BSAC). |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - CONTENTS |
|---|
| Formatted contents note |
TABLE OF CONTENTS<br/>List of Contributors vii<br/><br/>Preface ix<br/><br/>Foreword xiii<br/>Ada Yonath<br/><br/>1 Molecular Mechanisms of Antibiotic Resistance – Part I 1<br/>Alison J. Baylay, Laura J.V. Piddock, and Mark A. Webber<br/><br/>2 Molecular Mechanisms of Antibiotic Resistance – Part II 27<br/>Liam K.R. Sharkey and Alex J. O’Neill<br/><br/>3 Resistance to Glycopeptide Antibiotics 51<br/>François Lebreton and Vincent Cattoir<br/><br/>4 Resistance and Tolerance to Aminoglycosides 81<br/>Wendy W.K. Mok and Mark P. Brynildsen<br/><br/>5 Tetracyclines: Mode of Action and their Bacterial Mechanisms of Resistance 101<br/>Marilyn C. Roberts<br/><br/>6 Fluoroquinolone Resistance 125<br/>Karl Drlica, Xilin Zhao, Muhammad Malik, Hiroshi Hiasa, Arkady Mustaev, and Robert Kerns<br/><br/>7 Dihydropteroate Synthase (Sulfonamides) and Dihydrofolate Reductase Inhibitors 163<br/>Clemente Capasso and Claudiu T. Supuran<br/><br/>8 Anti‐tuberculosis Agents 173<br/>Ying Zhang<br/><br/>9 Multidrug Resistance 201<br/>Robert L. Marshall and Vassiliy N. Bavro<br/><br/>10 Anti‐virulence Therapies Through Potentiating ROS in Bacteria 239<br/>Kristin J. Adolfsen and Mark P. Brynildsen<br/><br/>Index 255 |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
AN AUTHORITATIVE SURVEY OF CURRENT RESEARCH INTO CLINICALLY USEFUL CONVENTIONAL AND NONCONVENTIONAL ANTIBIOTIC THERAPEUTICS<br/><br/>Pharmaceutically-active antibiotics revolutionized the treatment of infectious diseases, leading to decreased mortality and increased life expectancy. However, recent years have seen an alarming rise in the number and frequency of antibiotic-resistant "Superbugs." The Centers for Disease Control and Prevention (CDC) estimates that over two million antibiotic-resistant infections occur in the United States annually, resulting in approximately 23,000 deaths.<br/><br/>Despite the danger to public health, a minimal number of new antibiotic drugs are currently in development or in clinical trials by major pharmaceutical companies. To prevent reverting back to the pre-antibiotic era—when diseases caused by parasites or infections were virtually untreatable and frequently resulted in death—new and innovative approaches are needed to combat the increasing resistance of pathogenic bacteria to antibiotics.<br/><br/>Bacterial Resistance to Antibiotics – From Molecules to Man examines the current state and future direction of research into developing clinically-useful next-generation novel antibiotics. An internationally-recognized team of experts cover topics including glycopeptide antibiotic resistance, anti-tuberculosis agents, anti-virulence therapies, tetracyclines, the molecular and structural determinants of resistance, and more.<br/><br/>Presents a multidisciplinary approach for the optimization of novel antibiotics for maximum potency, minimal toxicity, and appropriated degradability<br/>Highlights critical aspects that may relieve the problematic medical situation of antibiotic resistance<br/>Includes an overview of the genetic and molecular mechanisms of antibiotic resistance<br/>Addresses contemporary issues of global public health and longevity<br/>Includes full references, author remarks, and color illustrations, graphs, and charts<br/>Bacterial Resistance to Antibiotics – From Molecules to Man is a valuable source of up-to-date information for medical practitioners, researchers, academics, and professionals in public health, pharmaceuticals, microbiology, and related fields. |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record and CIP data provided by publisher; resource not viewed. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Resistance, Bacterial |
| 655 #0 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Bonev, Boyan B., |
| Dates associated with a name |
1966- |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Brown, Nicholas M., |
| Dates associated with a name |
1962- |
| Relator term |
editor. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Link text |
Full text available at Wiley Online Library Click here to view |
| Uniform Resource Identifier |
https://onlinelibrary.wiley.com/doi/book/10.1002/9781119593522 |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
origcop |
| d |
1 |
| e |
ecip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS |
|---|
| Source of classification or shelving scheme |
|
| Item type |
EBOOK |